• Cengild Medical published its corporate governance report for the year ended June 30, 2026, disclosing departures on board gender diversity.
• Women held one of four board seats, or 25%, below the 30% target; the company will continue considering suitable candidates.
• No formal gender diversity policy covers the board or senior management.
• Independent directors represented 50% of the board; none had served more than nine years.
• The board has not adopted a policy limiting independent directors’ tenure to nine years without extensions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cengild Medical Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3719924) on October 29, 2026, and is solely responsible for the information contained therein.